207. Bad Bugs: Emerging High Consequence Viruses
Saturday, October 7, 2017: 8:30 AM-10:00 AM
Room: 14AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the clinical manifestations of Ebola and Lassa virus and New World Arenavirus infections  and disease epidemiology
  • describe the sequelae of Ebola and Lassa disease
  • list the latest updates in emerging poxviruses, and disease epidemiology

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Microbiologists, Pharmacists, Researchers, Scientists, Vaccinologists

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Adult ID, Trainee

Moderators:  Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases and Daniel Bausch, MD, MPH&TM, UK Public Health Rapid Support Team

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-298-L01-P


I. Damon, None

D. Bausch, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.